Masimo EPS - Earnings per Share 2010-2024 | MASI
Masimo annual and quarterly earnings per share history from 2010 to 2024. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Masimo EPS for the quarter ending December 31, 2024 was $-6.54, a 1138.1% decline year-over-year.
- Masimo EPS for the twelve months ending December 31, 2024 was $-5.72, a 478.81% decline year-over-year.
- Masimo 2024 annual EPS was $-5.72, a 478.81% decline from 2023.
- Masimo 2023 annual EPS was $1.51, a 41.92% decline from 2022.
- Masimo 2022 annual EPS was $2.6, a 34.67% decline from 2021.
| Masimo Annual EPS | |
|---|---|
| 2024 | $-5.72 |
| 2023 | $1.51 |
| 2022 | $2.60 |
| 2021 | $3.98 |
| 2020 | $4.14 |
| 2019 | $3.44 |
| 2018 | $3.45 |
| 2017 | $2.23 |
| 2016 | $5.85 |
| 2015 | $1.55 |
| 2014 | $1.30 |
| 2013 | $1.02 |
| 2012 | $1.07 |
| 2011 | $1.05 |
| 2010 | $1.21 |
| 2009 | $0.88 |
| Masimo Quarterly EPS | |
|---|---|
| 2024-12-31 | $-6.54 |
| 2024-09-30 | $0.18 |
| 2024-06-30 | $0.29 |
| 2024-03-31 | $0.35 |
| 2023-12-31 | $0.63 |
| 2023-09-30 | $0.20 |
| 2023-06-30 | $0.29 |
| 2023-03-31 | $0.39 |
| 2022-12-31 | $0.76 |
| 2022-09-30 | $0.70 |
| 2022-06-30 | $0.33 |
| 2022-03-31 | $0.81 |
| 2021-12-31 | $1.18 |
| 2021-09-30 | $1.00 |
| 2021-06-30 | $0.88 |
| 2021-03-31 | $0.92 |
| 2020-12-31 | $1.21 |
| 2020-09-30 | $0.85 |
| 2020-06-30 | $0.96 |
| 2020-03-31 | $1.12 |
| 2019-12-31 | $0.92 |
| 2019-09-30 | $0.86 |
| 2019-06-30 | $0.79 |
| 2019-03-31 | $0.87 |
| 2018-12-31 | $0.82 |
| 2018-09-30 | $1.02 |
| 2018-06-30 | $0.79 |
| 2018-03-31 | $0.82 |
| 2017-12-31 | $-0.14 |
| 2017-09-30 | $0.64 |
| 2017-06-30 | $0.80 |
| 2017-03-31 | $0.93 |
| 2016-12-31 | $4.23 |
| 2016-09-30 | $0.52 |
| 2016-06-30 | $0.57 |
| 2016-03-31 | $0.53 |
| 2015-12-31 | $0.45 |
| 2015-09-30 | $0.36 |
| 2015-06-30 | $0.36 |
| 2015-03-31 | $0.38 |
| 2014-12-31 | $0.40 |
| 2014-09-30 | $0.27 |
| 2014-06-30 | $0.24 |
| 2014-03-31 | $0.39 |
| 2013-12-31 | $0.17 |
| 2013-09-30 | $0.27 |
| 2013-06-30 | $0.30 |
| 2013-03-31 | $0.28 |
| 2012-12-31 | $0.26 |
| 2012-09-30 | $0.24 |
| 2012-06-30 | $0.30 |
| 2012-03-31 | $0.27 |
| 2011-12-31 | $0.23 |
| 2011-09-30 | $0.24 |
| 2011-06-30 | $0.28 |
| 2011-03-31 | $0.30 |
| 2010-12-31 | $0.26 |
| 2010-09-30 | $0.27 |
| 2010-06-30 | $0.24 |
| 2010-03-31 | $0.44 |
| 2009-12-31 | $0.22 |
| 2009-09-30 | $0.22 |
| 2009-06-30 | $0.22 |
| 2009-03-31 | $0.22 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.304B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $202.843B | 88.85 |
| Thermo Fisher Scientific (TMO) | United States | $153.281B | 18.54 |
| Edwards Lifesciences (EW) | United States | $45.022B | 29.52 |
| Alcon (ALC) | Switzerland | $43.031B | 29.08 |
| IDEXX Laboratories (IDXX) | United States | $40.969B | 47.08 |
| DexCom (DXCM) | United States | $33.925B | 52.44 |
| IQVIA Holdings (IQV) | United States | $24.535B | 13.74 |
| Mettler-Toledo (MTD) | United States | $23.231B | 27.63 |
| STERIS (STE) | Ireland | $22.352B | 24.65 |
| Waters (WAT) | United States | $20.553B | 29.00 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.219B | 0.00 |
| Hologic (HOLX) | United States | $12.337B | 13.40 |
| Penumbra (PEN) | United States | $11.191B | 87.83 |
| Sysmex ADR (SSMXY) | Japan | $10.965B | 31.11 |
| Globus Medical (GMED) | United States | $8.001B | 18.76 |
| Teleflex (TFX) | United States | $5.535B | 9.14 |
| Glaukos (GKOS) | United States | $5.232B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.173B | 21.87 |
| TransMedics (TMDX) | United States | $4.139B | 89.97 |
| PROCEPT BioRobotics (PRCT) | United States | $3.030B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.375B | 14.14 |
| Veracyte (VCYT) | United States | $2.231B | 31.31 |
| Nihon Kohden (NHNKY) | Japan | $2.050B | 23.51 |
| Elekta AB (EKTAY) | Sweden | $2.021B | 18.17 |
| Alphatec Holdings (ATEC) | United States | $1.862B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.522B | 0.00 |
| Artivion (AORT) | United States | $1.238B | 115.92 |
| Pulse Biosciences (PLSE) | United States | $1.097B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.004B | 5.34 |
| OPKO Health (OPK) | United States | $0.999B | 0.00 |
| SiBone (SIBN) | United States | $0.799B | 0.00 |
| IRadimed (IRMD) | United States | $0.660B | 33.49 |
| Mesa Laboratories (MLAB) | United States | $0.653B | 14.26 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.562B | 8.74 |
| Beta Bionics (BBNX) | United States | $0.557B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.555B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.539B | 0.00 |
| AxoGen (AXGN) | United States | $0.538B | 0.00 |
| RxSight (RXST) | United States | $0.538B | 0.00 |
| NeuroPace (NPCE) | United States | $0.512B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.467B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.423B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.377B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.363B | 9.66 |
| ClearPoint Neuro (CLPT) | United States | $0.348B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.330B | 0.00 |
| Neuronetics (STIM) | United States | $0.283B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.223B | 13.49 |
| Alpha Tau Medical (DRTS) | Israel | $0.199B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.170B | 0.00 |
| LENSAR (LNSR) | United States | $0.167B | 0.00 |
| Accuray (ARAY) | United States | $0.164B | 0.00 |
| Inogen (INGN) | United States | $0.158B | 0.00 |
| 908 Devices (MASS) | United States | $0.155B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.148B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.139B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.138B | 0.00 |
| CVRx (CVRX) | United States | $0.138B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.133B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.130B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.088B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.085B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.080B | 12.05 |
| InspireMD (NSPR) | Israel | $0.072B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.066B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.064B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.057B | 0.00 |
| Hyperfine (HYPR) | United States | $0.048B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.91 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |